Therapy Areas: Vaccines
3 July 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) and biotech firm CureVac N.V. (Nasdaq: CVAC) announced on Wednesday that they have restructured their collaboration into a new licensing...
3 July 2024 - P95 BV ('P95'), a Belgium-based global company involved in clinical and epidemiology research solutions, with a focus on vaccines and infectious diseases, announced on Tuesday ...
3 July 2024 - INOVIO (NASDAQ:INO), an American biotechnology company, announced on Tuesday that it has named Steven Egge as its new chief commercial officer.In the new role, Egge will head the firm�...
28 June 2024 - Dynavax Technologies Corporation (Nasdaq: DVAX), a California-based commercial-stage biopharmaceutical company, announced on Thursday that it has dosed its first participant in a phase ...
26 June 2024 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Wednesday that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (...
24 June 2024 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Monday that it has secured its second approval for IXCHIQ, its single-dose chikungunya vaccine.Health Canada a...